Research Article

Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated with Ovarian Teratoma in South China-Clinical Features, Treatment, Immunopathology, and Surgical Outcomes of 21 Cases

Table 1

General and clinical characteristics in patients having clinical improvement after surgery and patients having no improvement after surgery ().

ParametersPatients having improvement after surgery ()§Patients having no improvement after surgery ()

Age (y)-1.4030.178
Fertilized women3 (17.6%)2 (66.7%)0.140
History of ovarian surgery2 (11.8%)0 (0.0%)0.716
Clinical features [5]
 Prodromal symptoms
  Fever (°C)4 (23.5%)1 (33.3%)0.601
  Headache6 (35.3%)2 (66.7%)0.620
 Initial symptoms0.579
  Psychiatric abnormalities9 (52.9%)2 (66.7%)
  Seizures8 (47.1%)1 (33.3%)
 Psychiatric abnormalities17 (100.0%)3 (100.0%)-
 Seizures12 (70.6%)2 (66.7%)0.681
 Movement dysfunction10 (58.8%)2 (66.7%)0.656
 Loss of consciousness8 (47.1%)3 (100.0%)0.218
 Autonomic dysregulation10 (58.8%)1 (33.3%)0.566
 Speech disturbance6 (35.3%)2 (66.7%)0.537
 Central hypoventilation5 (29.4%)3 (100.0%)0.049
 Memory deficits2 (11.8%)0 (0.0%)0.716
Number of symptoms# [4]-1.6270.121
ICU admission [4]8 (47.1%)3 (100.0%)0.218
mRS at onset [4]-3.4900.003
Diameter of the ovarian teratoma (mm)-0.0250.980
Pathological type0.284
 Mature ovarian teratoma16 (94.1%)2 (66.7%)
 Immature ovarian teratoma1 (5.9%)1 (33.3%)
Time until surgery initiation (d)-0.9690.353

§A decrease in was defined as having clinical improvement after surgery. No change in mRS or for 1 month after surgery was defined as having no clinical improvement. #The eight symptom categories are as follows: psychiatric abnormalities, seizures, movement dysfunction, loss of consciousness, autonomic dysregulation, speech disturbance, central hypoventilation, and memory deficits. Fisher’s exact test. mRS: modified Rankin Scale; ICU: intensive care unit.